SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
February 8, 2021	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	0001193125-21-032310.pdf 0001193125-21-032310.rtf 0001193125-21-032310.xls View HTML
February 3, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-027403.pdf 0001193125-21-027403.rtf 0001193125-21-027403.xls View HTML
January 28, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-020896.pdf 0001193125-21-020896.rtf 0001193125-21-020896.xls View HTML
January 28, 2021	CORRESP	CORRESP	0001193125-21-020898.pdf 0001193125-21-020898.rtf View HTML
January 27, 2021	UPLOAD	UPLOAD	0000000000-21-001035.pdf 0000000000-21-001035.rtf View HTML
January 27, 2021	CORRESP	CORRESP	0001193125-21-019328.pdf 0001193125-21-019328.rtf 0001193125-21-019328.xls View HTML
January 22, 2021	S-1	Registration statement for face-amount certificate companies	0001193125-21-014818.pdf 0001193125-21-014818.rtf 0001193125-21-014818.xls View HTML
January 12, 2021	DRS/A	Amendment to a previously filed DRS	0000950123-21-000285.pdf 0000950123-21-000285.rtf 0000950123-21-000285.xls View HTML
January 8, 2021	UPLOAD	UPLOAD	0000000000-21-000231.pdf 0000000000-21-000231.rtf View HTML
December 11, 2020	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	0000950123-20-012596.pdf 0000950123-20-012596.rtf 0000950123-20-012596.xls View HTML

Data provided by Kaleidoscope.

Main Corporate Nav